New - European Medical Journal

Continue

News

Rheumatology
4 Sep 2017

Largest Ever Sample Study on Arthritis Yields Interesting Results

TODAY, the average American is twice as likely to be diagnosed with knee osteoarthritis than in the years leading up to World War II, according to a…
General Healthcare
31 Aug 2017

Introducing the European Medical Journal 2.3

United Kingdom, August 31, 2017: Welcome to this year’s third instalment of the European Medical Journal. This issue contains an abundance of…
Oncology
30 Aug 2017

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of…
Cardiology
30 Aug 2017

Study Results: Titanium-Nitride-Oxide (TiNO) Coated Stent Is Non-Inferior to Bioabsorbable Polymer Everolimus-Eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Barcelona, 29 August, 2017 – During the Late Breaking Science session at the European Society of Cardiology (ESC) Congress in Barcelona, Dr. Pim Tonino…
Allergy & Immunology
29 Aug 2017

The Potential of Immune Cells to Treat Allergy and Infection

SUCCESSFUL allergy and infection therapies may be possible following recent insights into the development and function of newly discovered Type 1…
Allergy & Immunology
29 Aug 2017

Reducing the Harmful Effects of Immune Cells

DISRUPTION of a key enzyme involved in immune cell-mediated damage has been researchers’ focus, in the hope of discovering a novel treatment target for a…
Oncology
24 Aug 2017

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.
General Healthcare
24 Aug 2017

Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…
We’ve noticed you’re accessing
from North/South America.